# QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events

> **NCT04514523** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 91 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus

## Interventions

- **OTHER:** QBSAfe Toolkit

## Key facts

- **NCT ID:** NCT04514523
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2020-09-22
- **Final completion:** 2020-09-22
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2023-01-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04514523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04514523, "QBSAfe: A Novel Approach to Diabetes Management Focused on Quality of Life, Burden of Treatment, Social Integration and Avoidance of Future Events". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04514523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*